Video

Harold Moses Jr, MD

Publish date: August 8, 2016

At the 39th Annual Contemporary Clinical Neurology Symposium, Dr. Moses discusses strategies for remyelination and neuropreservation in multiple sclerosis.

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Alemtuzumab beneficial for MS patients of African descent
ICYMI Multiple Sclerosis
Real-world MS relapse rate is low for dimethyl fumarate
ICYMI Multiple Sclerosis
Frederick Munschauer, MD
ICYMI Multiple Sclerosis
Choosing MS Treatments From the Therapeutic Armamentarium
ICYMI Multiple Sclerosis
Ocrelizumab May Be More Effective for Relapsing-Remitting MS Than Interferon
ICYMI Multiple Sclerosis
Can Stem Cells Halt Progression of MS?
ICYMI Multiple Sclerosis
Siponimod shows promise through 24 months in relapsing-remitting MS
ICYMI Multiple Sclerosis
Peter Chin, MD
ICYMI Multiple Sclerosis
Is Biotin an Effective Treatment for Progressive MS?
ICYMI Multiple Sclerosis
Abatacept fails to provide benefit in relapsing-remitting MS
ICYMI Multiple Sclerosis

Related Articles